Insider Trading Alert - PM, PANW, IMGN, CYBX And IT Traded By Insiders

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

Wednesday, Nov. 27, 2013, 160 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $788.24 to $484,583,953.98.

Highlighted Stocks Traded by Insiders:

Philip Morris International (PM) - FREE Research Report

Marchionne Sergio who is Director at Philip Morris International bought 1,000 shares at $86.29 on Nov. 27, 2013. Following this transaction, the Director owned 52,687 shares meaning that the stake was reduced by 1.93% with the 1,000 share transaction.

The shares most recently traded at $85.58, down $0.71, or 0.83% since the insider transaction. Historical insider transactions for Philip Morris International go as follows:

  • 4-Week # shares bought: 1,000
  • 4-Week # shares sold: 17,729
  • 12-Week # shares bought: 2,000
  • 12-Week # shares sold: 26,775
  • 24-Week # shares bought: 4,052
  • 24-Week # shares sold: 29,775

The average volume for Philip Morris International has been 5.2 million shares per day over the past 30 days. Philip Morris International has a market cap of $137.0 billion and is part of the consumer goods sector and tobacco industry. Shares are up 2.22% year to date as of the close of trading on Wednesday.

Philip Morris International Inc., through its subsidiaries, manufactures and sells cigarettes and other tobacco products. The stock currently has a dividend yield of 4.4%. The company has a P/E ratio of 16.2. Currently there are 9 analysts that rate Philip Morris International a buy, no analysts rate it a sell, and 3 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on PM - FREE

TheStreet Quant Ratings rates Philip Morris International as a hold. The company's strengths can be seen in multiple areas, such as its revenue growth, growth in earnings per share and good cash flow from operations. However, as a counter to these strengths, we find that the stock has had a generally disappointing performance in the past year. Get the full Philip Morris International Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

Palo Alto Networks (PANW) - FREE Research Report

Batra Rajiv who is VP, Engineering at Palo Alto Networks sold 15,000 shares at $50.00 on Nov. 27, 2013. Following this transaction, the VP, Engineering owned 176,100 shares meaning that the stake was reduced by 7.85% with the 15,000 share transaction.

The shares most recently traded at $49.68, down $0.32, or 0.64% since the insider transaction.

The average volume for Palo Alto Networks has been 1.2 million shares per day over the past 30 days. Palo Alto Networks has a market cap of $3.6 billion and is part of the technology sector and computer hardware industry. Shares are down 6.82% year to date as of the close of trading on Wednesday.

Palo Alto Networks, Inc. offers a network security platform in the Americas, Europe, the Middle East, Africa, the Asia Pacific, and Japan. The company's platform comprises Next-Generation Firewall that delivers application, user, and content visibility and control. Currently there are 11 analysts that rate Palo Alto Networks a buy, no analysts rate it a sell, and 9 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on PANW - FREE

TheStreet Quant Ratings rates Palo Alto Networks as a sell. The company's weaknesses can be seen in multiple areas, such as its deteriorating net income, generally disappointing historical performance in the stock itself and feeble growth in its earnings per share. Get the full Palo Alto Networks Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

Immunogen (IMGN) - FREE Research Report

Morris Charles Q who is Executive VP & CDO at Immunogen sold 12,500 shares at $13.75 on Nov. 27, 2013. Following this transaction, the Executive VP & CDO owned 37,500 shares meaning that the stake was reduced by 25% with the 12,500 share transaction.

The shares most recently traded at $14.49, up $0.74, or 5.11% since the insider transaction. Historical insider transactions for Immunogen go as follows:

  • 4-Week # shares sold: 12,500
  • 12-Week # shares sold: 12,500
  • 24-Week # shares sold: 12,500

The average volume for Immunogen has been 857,400 shares per day over the past 30 days. Immunogen has a market cap of $1.2 billion and is part of the health care sector and drugs industry. Shares are up 11.45% year to date as of the close of trading on Wednesday.

ImmunoGen, Inc., a biotechnology company, develops targeted anticancer therapeutics. The company develops its products using its targeted antibody payload technology. It offers Kadcyla, an antibody-drug conjugate for the treatment of HER2-positive metastatic breast cancer. Currently there are 5 analysts that rate Immunogen a buy, 2 analysts rate it a sell, and 4 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on IMGN - FREE

TheStreet Quant Ratings rates Immunogen as a sell. Among the areas we feel are negative, one of the most important has been weak operating cash flow. Get the full Immunogen Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

Cyberonics (CYBX) - FREE Research Report

Verratti Mark who is VP Global Sales at Cyberonics sold 3,661 shares at $67.96 on Nov. 27, 2013. Following this transaction, the VP Global Sales owned 52,719 shares meaning that the stake was reduced by 6.49% with the 3,661 share transaction.

The shares most recently traded at $69.36, up $1.40, or 2.03% since the insider transaction. Historical insider transactions for Cyberonics go as follows:

  • 4-Week # shares sold: 10,161
  • 12-Week # shares sold: 25,198
  • 24-Week # shares sold: 60,288

The average volume for Cyberonics has been 208,500 shares per day over the past 30 days. Cyberonics has a market cap of $1.9 billion and is part of the health care sector and health services industry. Shares are up 31.49% year to date as of the close of trading on Wednesday.

Cyberonics, Inc., together with its subsidiaries, engages in the design, development, marketing, and sale of implantable medical devices to hospitals and ambulatory surgery centers. The company has a P/E ratio of 40.6. Currently there are 6 analysts that rate Cyberonics a buy, no analysts rate it a sell, and 1 rates it a hold.

Exclusive Offer: Get the latest Stock Analysis on CYBX - FREE

TheStreet Quant Ratings rates Cyberonics as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures, increase in net income, growth in earnings per share and solid stock price performance. We feel these strengths outweigh the fact that the company is trading at a premium valuation based on our review of its current price compared to such things as earnings and book value. Get the full Cyberonics Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

Gartner (IT) - FREE Research Report

Lafond Christopher who is Cfo & Evp at Gartner sold 20,301 shares at $65.19 on Nov. 27, 2013. Following this transaction, the Cfo & Evp owned 27,659 shares meaning that the stake was reduced by 42.33% with the 20,301 share transaction.

The shares most recently traded at $65.17, down $0.02, or 0.03% since the insider transaction. Historical insider transactions for Gartner go as follows:

  • 4-Week # shares sold: 198,557
  • 12-Week # shares sold: 201,557
  • 24-Week # shares sold: 201,557

The average volume for Gartner has been 475,400 shares per day over the past 30 days. Gartner has a market cap of $6.0 billion and is part of the technology sector and computer software & services industry. Shares are up 42.55% year to date as of the close of trading on Wednesday.

Gartner, Inc. provides independent and objective research and analysis on information technology (IT), computer hardware, software, communications, and related technology industries. The company has a P/E ratio of 34.7. Currently there are 4 analysts that rate Gartner a buy, no analysts rate it a sell, and 5 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on IT - FREE

TheStreet Quant Ratings rates Gartner as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, impressive record of earnings per share growth, compelling growth in net income, expanding profit margins and solid stock price performance. We feel these strengths outweigh the fact that the company shows weak operating cash flow. Get the full Gartner Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

Data for this article provided by Zacks Investment Research
null

If you liked this article you might like

What's Behind the Hound of Hades' Stock Market Rampage

What's Behind the Hound of Hades' Stock Market Rampage

CDC Director Steps Down Following Report She Invested in Big Tobacco Stocks

CDC Director Steps Down Following Report She Invested in Big Tobacco Stocks

Tesla Refutes Report of Model 3 Delays: LIVE MARKETS BLOG

Tesla Refutes Report of Model 3 Delays: LIVE MARKETS BLOG

America's Opioid Crisis Looks a Lot Like Big Tobacco Spats of Yesteryear

America's Opioid Crisis Looks a Lot Like Big Tobacco Spats of Yesteryear

Philip Morris to Quit Cigarettes, Not Tobacco: LIVE MARKETS BLOG

Philip Morris to Quit Cigarettes, Not Tobacco: LIVE MARKETS BLOG